Organon (OGN) Non-Current Debt (2021 - 2026)

Organon (OGN) recorded quarterly Non-Current Debt of $8.6 billion in Q1 2026, down 0.87% quarter-over-quarter from $8.6 billion in Q4 2025, and down 4.29% on a YoY basis from $8.9 billion in Q1 2025.

Organon (OGN) Non-Current Debt (2021 - 2026) Analysis & Trends

Organon's Non-Current Debt history runs 6 years deep, the most recent figure standing at $8.6 billion for Q1 2026.

  • In Q1 2026, Non-Current Debt fell 4.29% year-over-year to $8.6 billion; the TTM figure through Mar 2026 stood at $8.6 billion (down 4.29% YoY), while the FY2025 annual figure was $8.6 billion, down 2.62% from the prior year.
  • Non-Current Debt was $8.6 billion for Q1 2026 at Organon, down from $8.6 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $9.1 billion in Q1 2022 to a low of $8.6 billion in Q1 2026.
  • Historically, Non-Current Debt has averaged $8.8 billion across 5 years, with a median of $8.7 billion in 2024.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Debt decreased 6.13% in 2022, then increased 2.65% in 2025.
  • A 5-year view of Non-Current Debt shows it stood at $8.9 billion in 2022, then slipped by 1.73% to $8.8 billion in 2023, then gained by 1.25% to $8.9 billion in 2024, then fell by 2.62% to $8.6 billion in 2025, then dropped by 0.87% to $8.6 billion in 2026.
  • The last three Non-Current Debt figures came in at $8.6 billion (Q1 2026), $8.6 billion (Q4 2025), and $8.8 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn -18.89 Bn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn 39.37 Bn
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn 37.53 Bn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn 64.53 Bn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn 46.67 Bn
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn 51.89 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 20.86 Bn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn 60.57 Bn
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn 42.15 Bn
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn 8.55 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.55 Bn
Mar 31, 2026 8.55 Bn
Dec 31, 2025 8.63 Bn
Dec 31, 2025 8.63 Bn
Sep 30, 2025 8.78 Bn
Sep 30, 2025 8.78 Bn
Jun 30, 2025 8.78 Bn
Jun 30, 2025 8.78 Bn
Mar 31, 2025 8.94 Bn
Mar 31, 2025 8.94 Bn
Dec 31, 2024 8.86 Bn
Dec 31, 2024 8.86 Bn
Sep 30, 2024 8.74 Bn
Sep 30, 2024 8.74 Bn
Jun 30, 2024 8.65 Bn
Jun 30, 2024 8.65 Bn
Mar 31, 2024 8.71 Bn
Mar 31, 2024 8.71 Bn
Dec 31, 2023 8.75 Bn
Dec 31, 2023 8.75 Bn